Munafa Stock Market Course + Intraday & FNO calls 
Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Crispr Therapeutics (CRSP)
Technical Analysis Report for USA stock CRSP Crispr Therapeutics. Dated: 05 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock CRSP Crispr Therapeutics then click here. or read Experts views on Crispr Therapeutics or Forecast & share price targets of Crispr Therapeutics
Crispr Therapeutics Opened at 58.40 and Closed at: 56.87, which is -2.27% of previous session's close. It moved within a range of 56.01 and 59.15
The session was a Bearish session with an average volume of 942681, which is -115.56% of previous session's volumes.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Golden cross was found 1 days back on short term averages
Support for tomorrow is 54.87 and resistance for tomorrow is 58.01
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 55.54, 54.2 resistance for tomorrow's hourly charts is 58.68, 60.48
10 Day SMA for Crispr Therapeutics (CRSP) is 53.65 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Crispr Therapeutics (CRSP) is 53.31 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Crispr Therapeutics (CRSP) is 61.48 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 59.52 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Crispr Therapeutics is 50.55 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Crispr Therapeutics is at 53.31 and 200 DMA is at 50.55, while 50 DMA and 100 DMA are at 61.48 and 59.52 respectively
Crispr Therapeutics (CRSP) moving average of 20 SMA is at 53.31 and 20 EMA is at 55.12
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Fri Dec | 56.87 | 53.31 | 55.12 |
| 04 Thu Dec | 58.16 | 53.29 | 54.94 |
| 03 Wed Dec | 55.99 | 53.24 | 54.6 |
| 02 Tue Dec | 51.58 | 53.26 | 54.45 |
| 01 Mon Dec | 52.17 | 53.88 | 54.75 |
| 28 Fri Nov | 53.47 | 54.47 | 55.02 |
Crispr Therapeutics (CRSP) moving average of 50 SMA is at 61.48 and 50 EMA is at 57.66
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Fri Dec | 56.87 | 61.48 | 57.66 |
| 04 Thu Dec | 58.16 | 61.55 | 57.69 |
| 03 Wed Dec | 55.99 | 61.61 | 57.67 |
| 02 Tue Dec | 51.58 | 61.71 | 57.74 |
| 01 Mon Dec | 52.17 | 61.92 | 57.99 |
| 28 Fri Nov | 53.47 | 62.12 | 58.23 |
Crispr Therapeutics (CRSP) moving average of 100 SMA is at 59.52 and 100 EMA is at 56.93
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Fri Dec | 56.87 | 59.52 | 56.93 |
| 04 Thu Dec | 58.16 | 59.5 | 56.93 |
| 03 Wed Dec | 55.99 | 59.45 | 56.91 |
| 02 Tue Dec | 51.58 | 59.45 | 56.93 |
| 01 Mon Dec | 52.17 | 59.5 | 57.04 |
| 28 Fri Nov | 53.47 | 59.57 | 57.14 |
Crispr Therapeutics (CRSP) moving average of 200 SMA is at 50.55 and 200 EMA is at 54.05
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Fri Dec | 56.87 | 50.55 | 54.05 |
| 04 Thu Dec | 58.16 | 50.53 | 54.02 |
| 03 Wed Dec | 55.99 | 50.49 | 53.98 |
| 02 Tue Dec | 51.58 | 50.43 | 53.96 |
| 01 Mon Dec | 52.17 | 50.39 | 53.98 |
| 28 Fri Nov | 53.47 | 50.32 | 54 |
Crispr Therapeutics has performed better than Molina Healthcare in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Mckesson Corporation in short term. Holding Crispr Therapeutics could be a better choice for now!
Herbalife Nutrition has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Herbalife Nutrition, about 31.11% more returns!
United Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in United Therapeutics, about 5.9% more returns!
Sol Gel has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Sol Gel, about 29.12% more returns!
Scynexis Inc has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Scynexis Inc, about 6.9% more returns!
Madrigal Pharmaceuticals has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Madrigal Pharmaceuticals, about 14.89% more returns!
Moleculin Biotech has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Moleculin Biotech, about 1374.45% more returns!
Healthcare Services has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Healthcare Services, about 6.29% more returns!
Grifols S has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Grifols S, about 1.76% more returns!
Crispr Therapeutics has performed better than Dbv Technologies in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Citius Pharmaceuticals in short term. Holding Crispr Therapeutics could be a better choice for now!
Celcuity Inc has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Celcuity Inc, about 38.65% more returns!
Cidara Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Cidara Therapeutics, about 107.99% more returns!
Axogen Inc has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Axogen Inc, about 38.27% more returns!
Crispr Therapeutics has performed better than Atossa Genetics in short term. Holding Crispr Therapeutics could be a better choice for now!
Arrowhead Pharmaceuticals has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Arrowhead Pharmaceuticals, about 53.47% more returns!
Crispr Therapeutics has performed better than Aldeyra Therapeutics in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics Technical analysis of indicators
Price action analysis of Crispr Therapeutics (CRSP) based on a short term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Crispr Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Crispr Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 53.56 and Crispr Therapeutics CRSP stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Crispr Therapeutics CRSP stock. Volume based technical analysis of Crispr Therapeutics CRSP stock is negative.
Crispr Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock CRSP Crispr Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CRSP Experts View which covers a lot of information including buying and selling signals
CRSP future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Crispr Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
